What is Prime Medicine's book value per share?

Prime Medicine (PRME) reported book value per share of $0.43 in Q1 2026.

How has Prime Medicine's book value per share changed year-over-year?

Prime Medicine's book value per share decreased by 47.0% year-over-year, from $0.82 to $0.43.

What is the long-term trend for Prime Medicine's book value per share?

Over 5 years (2020 to 2025), Prime Medicine's book value per share has grown at a -1.7% compound annual growth rate (CAGR), from $0.89 to $0.81.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Prime Medicine PRME Book value per share

Book value per share at other companies

Eli LillyLLY

$34.82+98.9%

Vertex PharmaceuticalsVRTX

$75.54+18.8%

Intellia TherapeuticsNTLA

$5.24-30.5%

CRISPR TherapeuticsCRSP

$18.89-11.2%

Beam TherapeuticsBEAM

$11.28-12.2%

RegenxbioRGNX

$0.40-92.5%

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Calculated from Prime Medicine’s reported figures.

total stockholders equity/weighted shares diluted=$0.43

Based on the most recent quarter.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's book value per share?: Prime Medicine (PRME) reported book value per share of $0.43 in Q1 2026.
How has Prime Medicine's book value per share changed year-over-year?: Prime Medicine's book value per share decreased by 47.0% year-over-year, from $0.82 to $0.43.
What is the long-term trend for Prime Medicine's book value per share?: Over 5 years (2020 to 2025), Prime Medicine's book value per share has grown at a -1.7% compound annual growth rate (CAGR), from $0.89 to $0.81.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.